A Multicenter, Randomized, Double-Blind, Double-Dummy Study Of Azithromycin SR Versus Amoxicillin For The Treatment Of Strep Throat In Children
Public ClinicalTrials.gov record NCT00643149. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial Of Azithromycin SR Versus Amoxicillin For The Treatment Of Group A Β-Hemolytic Streptococcal Pharyngitis/Tonsillitis In Children
Study identification
- NCT ID
- NCT00643149
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 693 participants
Conditions and interventions
Conditions
Interventions
- amoxicillin Drug
- azithromycin SR Drug
Drug
Eligibility (public fields only)
- Age range
- 2 Years to 12 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2003
- Primary completion
- Not listed
- Completion
- Feb 29, 2004
- Last update posted
- May 16, 2011
2003 – 2004
United States locations
- U.S. sites
- 33
- U.S. states
- 12
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Hoover | Alabama | 35244 | — |
| Pfizer Investigational Site | Pelham | Alabama | 35124 | — |
| Pfizer Investigational Site | Fresno | California | 93710 | — |
| Pfizer Investigational Site | Fresno | California | 93720 | — |
| Pfizer Investigational Site | San Diego | California | 92128 | — |
| Pfizer Investigational Site | Evansville | Indiana | 47710 | — |
| Pfizer Investigational Site | Evansville | Indiana | 47713 | — |
| Pfizer Investigational Site | Evansville | Indiana | 47714 | — |
| Pfizer Investigational Site | Newburgh | Indiana | 47360 | — |
| Pfizer Investigational Site | Newburgh | Indiana | 47630 | — |
| Pfizer Investigational Site | Wichita | Kansas | 67207 | — |
| Pfizer Investigational Site | Wichita | Kansas | 67212 | — |
| Pfizer Investigational Site | Bardstown | Kentucky | 40004 | — |
| Pfizer Investigational Site | Springfield | Kentucky | 40069 | — |
| Pfizer Investigational Site | Kalamazoo | Michigan | 49009 | — |
| Pfizer Investigational Site | Endwell | New York | 13760 | — |
| Pfizer Investigational Site | Raleigh | North Carolina | 27609 | — |
| Pfizer Investigational Site | Beachwood | Ohio | 44122 | — |
| Pfizer Investigational Site | Chesterland | Ohio | 44026 | — |
| Pfizer Investigational Site | Cleveland | Ohio | 44106 | — |
| Pfizer Investigational Site | Cleveland | Ohio | 44111 | — |
| Pfizer Investigational Site | Willoughby | Ohio | 44094 | — |
| Pfizer Investigational Site | Youngstown | Ohio | 44501 | — |
| Pfizer Investigational Site | McMurray | Pennsylvania | 15317 | — |
| Pfizer Investigational Site | Pittsburgh | Pennsylvania | 15234 | — |
| Pfizer Investigational Site | Pittsburgh | Pennsylvania | 15241 | — |
| Pfizer Investigational Site | Bryan | Texas | 77802 | — |
| Pfizer Investigational Site | Lake Jackson | Texas | 77566 | — |
| Pfizer Investigational Site | Salt Lake City | Utah | 84103 | — |
| Pfizer Investigational Site | Salt Lake City | Utah | 84109 | — |
| Pfizer Investigational Site | Salt Lake City | Utah | 84111 | — |
| Pfizer Investigational Site | Salt Lake City | Utah | 84121 | — |
| Pfizer Investigational Site | West Jordan | Utah | 84088 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00643149, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 16, 2011 · Synced May 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00643149 live on ClinicalTrials.gov.